Scholars@Duke

NICE to rule on influenza flu drug zanamivir.

Publication ,  Journal Article
Yamey, G
Published in: BMJ (Clinical research ed.)
October 1999
Published version (DOI)

Duke Scholars

Gavin Mark Yamey
Author Gavin Mark Yamey Duke Global Health Institute

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.319.7215.937

EISSN

1756-1833

ISSN

0959-8138

Publication Date

October 1999

Volume

319

Issue

7215

Start / End Page

937

Related Subject Headings

  • Zanamivir
  • Sialic Acids
  • Pyrans
  • National Health Programs
  • Influenza, Human
  • Humans
  • Guanidines
  • General & Internal Medicine
  • Antiviral Agents
  • Academies and Institutes
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yamey, G. (1999). NICE to rule on influenza flu drug zanamivir. BMJ (Clinical Research Ed.), 319(7215), 937. https://doi.org/10.1136/bmj.319.7215.937
Yamey, G. “NICE to rule on influenza flu drug zanamivir.” BMJ (Clinical Research Ed.) 319, no. 7215 (October 1999): 937. https://doi.org/10.1136/bmj.319.7215.937.
Yamey G. NICE to rule on influenza flu drug zanamivir. BMJ (Clinical research ed). 1999 Oct;319(7215):937.
Yamey, G. “NICE to rule on influenza flu drug zanamivir.” BMJ (Clinical Research Ed.), vol. 319, no. 7215, Oct. 1999, p. 937. Epmc, doi:10.1136/bmj.319.7215.937.
Yamey G. NICE to rule on influenza flu drug zanamivir. BMJ (Clinical research ed). 1999 Oct;319(7215):937.

Published In

BMJ (Clinical research ed.)

DOI

10.1136/bmj.319.7215.937

EISSN

1756-1833

ISSN

0959-8138

Publication Date

October 1999

Volume

319

Issue

7215

Start / End Page

937

Related Subject Headings

  • Zanamivir
  • Sialic Acids
  • Pyrans
  • National Health Programs
  • Influenza, Human
  • Humans
  • Guanidines
  • General & Internal Medicine
  • Antiviral Agents
  • Academies and Institutes